Aptar to introduce innovative respiratory solutions at Cphl

Pharma trade and networking platform in China


Aptar Pharma, a global solution provider in the design, development and manufacturing of proven drug delivery devices for biotech, healthcare and pharma partners , will be exhibiting at Cphl China, Asia’s leading trade and networking platform, between 20 and 22 June 2018 at the Shanghai New International Exhibition Center, Shanghai, China. Cphl China has invited the entire pharma industry chain of 40,000 experts from over 120 countries to network and collaborate on the forthcoming trends for China’s pharma market.

Aptar Pharma will display new market innovations in inhalation drug delivery for respiratory solutions to combat the effects of air pollution in China.

In addition, the company will also exhibit its innovative Connected Device portfolio for respiratory and eye care. The exhibition will offer visitors a chance to explore the innovative devices featuring fully-connected functionality and software integration for improving patient health outcomes.

Aptar Pharma will also display its drug delivery systems expertise in dermal innovation. Specialists will be on hand to discuss the newly enhanced dispensing solutions for Aptar Pharma’s Airless Dermal Drug Delivery Systems, providing insight into how their technologies and features can support pharmaceutical professionals’ drug formulations and consumer products.

A seminar will be conducted by Aptar Pharma on 22 June, during which two experts from the company will present two interactive sessions. While Guenter Nadler, director — business development consumer health care division, will talk about ‘Healthy Nose, Healthy Life: A Glance at Global Successful Products for Upper Respiratory Health’, Tianjiao Fu, business development manager China, pharma sales., will make his presentation on ‘Say No to Preservatives: Package Innovation for Ophthalmic & Dermal Products’. The sessions will be followed by a Q&A round.

Commenting on the exhibition, Nadler said, “We are delighted to once again participate in CPhI China, which connects us with the entire Chinese pharmaceutical market. We look forward to showcasing our new market innovations and demonstrating our expertise to industry leaders through our broad drug delivery solutions and our seminar presentations at this event.”


Please enter your comment!
Please enter your name here